Search results
Yusuf Khwaja Hamied (born 25 July 1936) is an Indian scientist, billionaire businessman and the chairman of Cipla, a generic pharmaceuticals company founded by his father Khwaja Abdul Hamied in 1935. He is also an elected fellow of the Indian National Science Academy .
Yusuf Khwaja Hamied is an Indian scientist and a prominent businessman. He is the chairman of Cipla, an Indian company that makes generic medicines. His father, Khwaja Abdul Hamied, started the Cipla company in 1935. Yusuf Hamied is a fellow member of the Indian National Science Academy.
Jun 25, 2024 · Yusuf Hamied is the non-executive chairman of Mumbai-based generics maker Cipla. Cipla was founded in 1935 by his father Khwaja Abdul Hamied, a disciple of Mahatma Gandhi.
Oct 11, 2023 · Yusuf Hamied is the non-executive chairman of $2.8 billion (revenue) generics maker Cipla. The company was founded in 1935 by his father Khwaja Abdul Hamied, a disciple of Mahatma...
Yusuf Hamied is Chairman, Cipla, a leading pharmaceutical company established in India in 1935. He graduated with honours from Cambridge University in 1957 and continued to a PhD in 1960 under the tutelage of the Nobel Laureate, Alexander Todd.
Jan 28, 2022 · Yusuf Hamied joined the family business in 1960 and became prominent for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatments and...
Yusuf Hamied became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatments and other drugs to treat poor people in the developing world.
Today, as Non-Executive Chairman of the company now known as CIPLA, Yusuf Hamied keeps a close watch on his family's generic drugs giant, which turns over US$2 billion annually and employs around 26 000 people in India and several other locations worldwide.
May 7, 2009 · Spurred on by that fact, Yusuf Hamied, chairman and managing director of Cipla Pharmaceuticals, has steered his enterprise to the forefront of global pharmaceutical development by manufacturing low-cost drugs for diseases like AIDS, diabetes and arthritis, among others.
Yusuf Hamied, 84, chairman of Cipla, recalls the time when he was called a pirate. That was in 2001, and Hamied’s company was offering to sell for $1 a day, or around $350 a year, the then...
